Market Access - a life cycle approach
•
0 likes•167 views
Getting a drug to market is a long lasting process from early development till product's end of life. Needs and requirements are changing over time.
Recommended
Recommended
More Related Content
Recently uploaded
Recently uploaded (20)
Featured
Featured (20)
Market Access - a life cycle approach
- 1. A comprehensive process A way of thinking A life cycle approach Market Access May 18, 2017 Market Access Life Cycle
- 2. © 2017 pharmaLevers GmbH Market Access Process May 18, 2017 2 Pre- launch launch Post - launch Mainte nance R&DSubject Time Horizon Objective Barriers Uncertainty Requirement Tools KPI’s <15-3yr 0-1 yr< 2-3 yr >1-2 yr > 2 yr Medial need ReimbursementApproval Uptake Keep plateau Input PerceptionData Evidence Policy Future DecisionsTiming Uptake Competition HTA input Value DossierCTD RWE Defend price Advisory Boards HTA ReportStake. Mgmt. Outcome Res. Contracting Design $ ReimbursedApproval time # Publications Market share Market Access Life Cycle
- 3. © 2017 pharmaLevers GmbH Get in touch with pharmaLevers GmbH pharmaLevers GmbH Kurt R. Müller, PhD Principal and Managing Director Mittlere Bühnenbergstrasse 16 CH- 4665 Oftringen SWITZERLAND / SUISSE Phone: +41 62 798 04 33 Mobile: +41 79 636 63 96 Email: kurt.mueller@pharmalevers.com Web: http://www.pharmalevers.com http://www.linkedin.com/in/drkurtmueller http://twitter.com/pharmalevers May 18, 2017 3 Market Access Life Cycle